On June 6, 2021, the FDA published “Important Patient and Consumer Information About Regenerative Medicine Therapies”. This statement was intended to caution the public about “Stem Cell” clinics who have been making false and fraudulent statements publicly and performing unapproved and potentially dangerous or life-threatening procedures without sound scientific proof for safety or efficacy.

Please trust that the Innovative Sports Medicine (ISM) crew is following current FDA directives and committed to the ethical use of cell treatments. As a Bluetail Medical Affiliate, ISM has aligned with physicians conducting clinical research.  Currently we have an Investigational New Drug Number (IND#27390) for the use of bone marrow concentrate as a treatment of knee osteoarthritis, and others will follow.  

Stay informed. Stay safe.